Drug-induced liver injury (DILI) via metabolic activation by; drug-metabolizing enzymes, especially Cytochrome P450 (GYP), is a major,cause of drug failure and drug withdrawal., In this study; an in vitro model using HepG2 cells in combination with human liver microsomes was developed for the prediction of DILI. The cytotoxicity of cyclophosphamide, a model drug, for bioactivation was augmented in HepG2 cells cultured with microsomes in a manner dependent on exposure time, microsomal protein concentration, and NADPH Experiments using pan- or isoform-selective GYP inhibitors showed that CYP2B6 and CYP3A4 are responsible for the bioactivation of cyclophosphamide. In a metabolite identification study employing LC-ESI-QTrap and LC-ESI-QTOF, cyc...
We have integrated in vitro and in silico information to investigate acetaminophen (APAP) and its me...
We have integrated in vitro and in silico information to investigate acetaminophen (APAP) and its me...
Cytochrome P450 (CYP) is the most important phase I drug-metabolizing enzyme, and the effect of drug...
In a number of adverse drug reactions leading to hepatotoxicity drug metabolism is thought to be inv...
In drug development, a system for predicting drug metabolism and drug‐induced toxicity is necessary ...
There is an increasing need for development of physiologically relevant in-vitro models for testing ...
Drug-induced liver injury (DILI) is a severe health condition that may result in morbidity and morta...
Drug-induced liver injury (DILI) is a severe health condition that may result in morbidity and morta...
There is an increasing need for development of physiologically relevant in-vitro models for testing ...
Drug-induced liver injury (DILI) is a severe health condition that may result in morbidity and morta...
Drug-induced liver injury (DILI) is a severe health condition that may result in morbidity and morta...
Xenobiotics or their metabolite(s) can be electrophilic or free radicals that elicit a variety of ch...
Drug-induced liver injury (DILI) is a severe health condition that may result in morbidity and morta...
Drug-induced liver injury remains a frequent reason for drug withdrawal. Accordingly, more predictiv...
Xenobiotics or their metabolite(s) can be electrophilic or free radicals that elicit a variety of ch...
We have integrated in vitro and in silico information to investigate acetaminophen (APAP) and its me...
We have integrated in vitro and in silico information to investigate acetaminophen (APAP) and its me...
Cytochrome P450 (CYP) is the most important phase I drug-metabolizing enzyme, and the effect of drug...
In a number of adverse drug reactions leading to hepatotoxicity drug metabolism is thought to be inv...
In drug development, a system for predicting drug metabolism and drug‐induced toxicity is necessary ...
There is an increasing need for development of physiologically relevant in-vitro models for testing ...
Drug-induced liver injury (DILI) is a severe health condition that may result in morbidity and morta...
Drug-induced liver injury (DILI) is a severe health condition that may result in morbidity and morta...
There is an increasing need for development of physiologically relevant in-vitro models for testing ...
Drug-induced liver injury (DILI) is a severe health condition that may result in morbidity and morta...
Drug-induced liver injury (DILI) is a severe health condition that may result in morbidity and morta...
Xenobiotics or their metabolite(s) can be electrophilic or free radicals that elicit a variety of ch...
Drug-induced liver injury (DILI) is a severe health condition that may result in morbidity and morta...
Drug-induced liver injury remains a frequent reason for drug withdrawal. Accordingly, more predictiv...
Xenobiotics or their metabolite(s) can be electrophilic or free radicals that elicit a variety of ch...
We have integrated in vitro and in silico information to investigate acetaminophen (APAP) and its me...
We have integrated in vitro and in silico information to investigate acetaminophen (APAP) and its me...
Cytochrome P450 (CYP) is the most important phase I drug-metabolizing enzyme, and the effect of drug...